Name | AG 490 |
---|---|
Supplier | R&D Systems |
Catalog | 0414 |
Prices | $109.00, $459.00 |
Sizes | 10 mg, 50 mg |
Cas Number | 133550-30-8 |
Chemical Name | (E)-2-Cyano-3-(3,4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide |
Formula | C17H14N2O3 |
Molecular Weight | 294.31 |
Purity | >99% |
Supplier Page | Shop |
Shenoy A, Danial M, Blelloch RH. EMBO J. 2015 May 5;34(9):1180-94.
Zhao LC, Li J, Liao K, Luo N, Shi QQ, Feng ZQ, Chen DL. Int J Mol Sci. 2015 Nov 16;16(11):27411-21.
Tactacan CM, Phua YW, Liu L, Zhang L, Humphrey ES, Cowley M, Pinese M, Biankin AV, Daly RJ. Mol Cancer. 2015 Jul 29;14:139.
Jiang WG, Ye L, Ruge F, Owen S, Martin T, Sun PH, Sanders AJ, Lane J, Satherley L, Weeks HP, Gao Y, Wei C, Wu Y, Mason MD. J Transl Med. 2015 Aug 27;13:280.
Rogers SW, Gahring LC. PLoS One. 2015 Nov 30;10(11):e0143319.
Kubota H, Nagao S, Obata K, Hirono M. PLoS One. 2014 Sep 2;9(9):e106316.
Park SJ, Shin EJ, Min SS, An J, Li Z, Hee Chung Y, Hoon Jeong J, Bach JH, Nah SY, Kim WK, Jang CG, Kim YS, Nabeshima Y, Nabeshima T, Kim HC. Neuropsychopharmacology. 2013 Jul;38(8):1426-37.
Jung SN, Yang WK, Kim J, Kim HS, Kim EJ, Yun H, Park H, Kim SS, Choe W, Kang I, Ha J. Carcinogenesis. 2008 Apr;29(4):713-21.